Biotech Stocks
Novartis telegraphs 130 job cuts amid biologics rethink in Switzerland
FiercePharma
2h ago
Restructuring
Novartis could cut about 130 jobs in Switzerland as it rethinks its biologics technical development and production footprint in Basel.
Discussion
Sign in to join the discussion. Comments loading…